The Methuselah Foundation, a charity devoted to innovation in regenerative medicine, will divvy up at least $500,000 in the form of grants between selected public and private research universities and private non-profit research institutes, Organovo Holdings, Inc., a San Diego-based biotech company, announced today. The catch? Eligibility is limited to those research institutions using Organovo’s NovoGen Bioprinting technology.
Initial funding, which will go to cover bioprinter costs and/or project execution, is available now, and will start being doled out as soon as candidates are selected. Organovo will participate in that selection.
